ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ketorolac Injection Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-24Z7589
Home | Market Reports | Health| Health Conditions| Pain Management
Global Ketorolac Injection Market Research Report 2022
BUY CHAPTERS

Global Ketorolac Injection Market Research Report 2024

Code: QYRE-Auto-24Z7589
Report
March 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fresenius Kabi
Hikma
Pfizer Inc
Alvogen
Athenex Inc
Sagent Pharmaceuticals
Lunan Pharma
Tianjin Chase Sun Pharmaceutical
Fosun Pharma (Gland Pharma)
Chengdu Brilliant Pharmaceuticals
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
ZISKA Pharmaceuticals

Ketorolac Injection Market Size

The global Ketorolac Injection market was valued at US$ 939.8 million in 2023 and is anticipated to reach US$ 1125.6 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.

Ketorolac Injection Market

Ketorolac Injection Market Trends

The market for ketorolac injections is expanding due to its clinical effectiveness in treating moderate to severe acute pain, positioning it as a competitive option to opioid analgesics. A nonsteroidal anti-inflammatory medication (NSAID), ketorolac effectively relieves pain without the dangers of opiate dependence, addiction, or respiratory depression. Given the present state of the opioid crisis and the emphasis on lowering opioid usage, this function is especially appealing in the context of healthcare. Ketorolac's capacity to lessen the need for opioids after surgery or in emergency situations increases its allure in hospitals and outpatient care settings, which is a major factor in the drug's market expansion.

Furthermore, a rise in surgical procedures worldwide, especially elective surgeries, which commonly need for efficient postoperative pain treatment, is contributing to the market expansion for ketorolac injections. The demand for efficient postoperative pain management, such as ketorolac injections, is increasing as the healthcare infrastructure advances and surgical therapies become more widely available, particularly in developing nations. It is also perfect for use in acute care settings due to its ease of injection administration, which relieves pain more quickly than oral versions. The market for ketorolac injections is growing due to these causes as well as a growing awareness among healthcare professionals of the advantages of non-opioid pain management options.

Ketorolac Injection Market Share

Global leading manufacturers of ketorolac injections include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), and others. 20% of the market is held by the top 2 companies. With a market share of around 40%, North America leads the market, followed by Asia-Pacific and Europe, with respective shares of roughly 27% and 20%. With a market share of more than 64%, the 30 mg/ml ketorolac injection is the largest product category. Hospitals are the greatest application in terms of size, followed by clinics. 

Scope of Ketorolac Injection Market Report

Report Metric Details
Report Name Ketorolac Injection Market
Accounted market size in 2023 US$ 939.8 million
Forecasted market size in 2030 US$ 1125.6 million
CAGR 2.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Concentration
  • 15mg/ml
  • 30mg/ml
Segment by Application
  • Hospital
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, Julphar Bangladesh Ltd., Yung Shin Pharm, Tianjin Chase Sun Pharmaceutical, ZISKA Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Concentration, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ketorolac Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ketorolac Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Concentration, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ketorolac Injection Market growing?

Ans: The Ketorolac Injection Market witnessing a CAGR of 2.7% during the forecast period 2024-2030.

What is the Ketorolac Injection Market size in 2030?

Ans: The Ketorolac Injection Market size in 2030 will be US$ 1125.6 million.

What is the market share of major companies in Ketorolac Injection Market?

Ans: The top 2 companies hold a share about 20%.

What is the Ketorolac Injection Market share by region?

Ans: North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%.

Who are the main players in the Ketorolac Injection Market report?

Ans: The main players in the Ketorolac Injection Market are Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, Julphar Bangladesh Ltd., Yung Shin Pharm, Tianjin Chase Sun Pharmaceutical, ZISKA Pharmaceuticals

What are the Application segmentation covered in the Ketorolac Injection Market report?

Ans: The Applications covered in the Ketorolac Injection Market report are Hospital, Clinics, Others

1 Ketorolac Injection Market Overview
1.1 Product Overview and Scope of Ketorolac Injection
1.2 Ketorolac Injection Segment by Concentration
1.2.1 Global Ketorolac Injection Market Value Comparison by Concentration (2024-2030)
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Ketorolac Injection Segment by Application
1.3.1 Global Ketorolac Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Ketorolac Injection Market Size Estimates and Forecasts
1.4.1 Global Ketorolac Injection Revenue 2019-2030
1.4.2 Global Ketorolac Injection Sales 2019-2030
1.4.3 Global Ketorolac Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ketorolac Injection Market Competition by Manufacturers
2.1 Global Ketorolac Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ketorolac Injection Average Price by Manufacturers (2019-2024)
2.4 Global Ketorolac Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ketorolac Injection, Product Type & Application
2.7 Ketorolac Injection Market Competitive Situation and Trends
2.7.1 Ketorolac Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ketorolac Injection Players Market Share by Revenue
2.7.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ketorolac Injection Retrospective Market Scenario by Region
3.1 Global Ketorolac Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ketorolac Injection Global Ketorolac Injection Sales by Region: 2019-2030
3.2.1 Global Ketorolac Injection Sales by Region: 2019-2024
3.2.2 Global Ketorolac Injection Sales by Region: 2025-2030
3.3 Global Ketorolac Injection Global Ketorolac Injection Revenue by Region: 2019-2030
3.3.1 Global Ketorolac Injection Revenue by Region: 2019-2024
3.3.2 Global Ketorolac Injection Revenue by Region: 2025-2030
3.4 North America Ketorolac Injection Market Facts & Figures by Country
3.4.1 North America Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ketorolac Injection Sales by Country (2019-2030)
3.4.3 North America Ketorolac Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ketorolac Injection Market Facts & Figures by Country
3.5.1 Europe Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ketorolac Injection Sales by Country (2019-2030)
3.5.3 Europe Ketorolac Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ketorolac Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ketorolac Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Ketorolac Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Ketorolac Injection Market Facts & Figures by Country
3.7.1 Latin America Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ketorolac Injection Sales by Country (2019-2030)
3.7.3 Latin America Ketorolac Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Ketorolac Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ketorolac Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ketorolac Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Concentration
4.1 Global Ketorolac Injection Sales by Concentration (2019-2030)
4.1.1 Global Ketorolac Injection Sales by Concentration (2019-2024)
4.1.2 Global Ketorolac Injection Sales by Concentration (2025-2030)
4.1.3 Global Ketorolac Injection Sales Market Share by Concentration (2019-2030)
4.2 Global Ketorolac Injection Revenue by Concentration (2019-2030)
4.2.1 Global Ketorolac Injection Revenue by Concentration (2019-2024)
4.2.2 Global Ketorolac Injection Revenue by Concentration (2025-2030)
4.2.3 Global Ketorolac Injection Revenue Market Share by Concentration (2019-2030)
4.3 Global Ketorolac Injection Price by Concentration (2019-2030)
5 Segment by Application
5.1 Global Ketorolac Injection Sales by Application (2019-2030)
5.1.1 Global Ketorolac Injection Sales by Application (2019-2024)
5.1.2 Global Ketorolac Injection Sales by Application (2025-2030)
5.1.3 Global Ketorolac Injection Sales Market Share by Application (2019-2030)
5.2 Global Ketorolac Injection Revenue by Application (2019-2030)
5.2.1 Global Ketorolac Injection Revenue by Application (2019-2024)
5.2.2 Global Ketorolac Injection Revenue by Application (2025-2030)
5.2.3 Global Ketorolac Injection Revenue Market Share by Application (2019-2030)
5.3 Global Ketorolac Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Ketorolac Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Ketorolac Injection Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Fosun Pharma (Gland Pharma)
6.3.1 Fosun Pharma (Gland Pharma) Corporation Information
6.3.2 Fosun Pharma (Gland Pharma) Description and Business Overview
6.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Portfolio
6.3.5 Fosun Pharma (Gland Pharma) Recent Developments/Updates
6.4 Sagent Pharmaceuticals
6.4.1 Sagent Pharmaceuticals Corporation Information
6.4.2 Sagent Pharmaceuticals Description and Business Overview
6.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sagent Pharmaceuticals Ketorolac Injection Product Portfolio
6.4.5 Sagent Pharmaceuticals Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Ketorolac Injection Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Lunan Pharma
6.6.1 Lunan Pharma Corporation Information
6.6.2 Lunan Pharma Description and Business Overview
6.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lunan Pharma Ketorolac Injection Product Portfolio
6.6.5 Lunan Pharma Recent Developments/Updates
6.7 Alvogen
6.6.1 Alvogen Corporation Information
6.6.2 Alvogen Description and Business Overview
6.6.3 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Alvogen Ketorolac Injection Product Portfolio
6.7.5 Alvogen Recent Developments/Updates
6.8 Chengdu Brilliant Pharmaceuticals
6.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information
6.8.2 Chengdu Brilliant Pharmaceuticals Description and Business Overview
6.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Portfolio
6.8.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
6.9 Athenex
6.9.1 Athenex Corporation Information
6.9.2 Athenex Description and Business Overview
6.9.3 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Athenex Ketorolac Injection Product Portfolio
6.9.5 Athenex Recent Developments/Updates
6.10 Sichuan Medcalo
6.10.1 Sichuan Medcalo Corporation Information
6.10.2 Sichuan Medcalo Description and Business Overview
6.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sichuan Medcalo Ketorolac Injection Product Portfolio
6.10.5 Sichuan Medcalo Recent Developments/Updates
6.11 Julphar Bangladesh Ltd.
6.11.1 Julphar Bangladesh Ltd. Corporation Information
6.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Description and Business Overview
6.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Product Portfolio
6.11.5 Julphar Bangladesh Ltd. Recent Developments/Updates
6.12 Yung Shin Pharm
6.12.1 Yung Shin Pharm Corporation Information
6.12.2 Yung Shin Pharm Ketorolac Injection Description and Business Overview
6.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Yung Shin Pharm Ketorolac Injection Product Portfolio
6.12.5 Yung Shin Pharm Recent Developments/Updates
6.13 Tianjin Chase Sun Pharmaceutical
6.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information
6.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Description and Business Overview
6.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Portfolio
6.13.5 Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
6.14 ZISKA Pharmaceuticals
6.14.1 ZISKA Pharmaceuticals Corporation Information
6.14.2 ZISKA Pharmaceuticals Ketorolac Injection Description and Business Overview
6.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ZISKA Pharmaceuticals Ketorolac Injection Product Portfolio
6.14.5 ZISKA Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ketorolac Injection Industry Chain Analysis
7.2 Ketorolac Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ketorolac Injection Production Mode & Process
7.4 Ketorolac Injection Sales and Marketing
7.4.1 Ketorolac Injection Sales Channels
7.4.2 Ketorolac Injection Distributors
7.5 Ketorolac Injection Customers
8 Ketorolac Injection Market Dynamics
8.1 Ketorolac Injection Industry Trends
8.2 Ketorolac Injection Market Drivers
8.3 Ketorolac Injection Market Challenges
8.4 Ketorolac Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Fresenius Kabi
Hikma
Pfizer Inc
Alvogen
Athenex Inc
Sagent Pharmaceuticals
Lunan Pharma
Tianjin Chase Sun Pharmaceutical
Fosun Pharma (Gland Pharma)
Chengdu Brilliant Pharmaceuticals
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
ZISKA Pharmaceuticals
List of Tables
    Table 1. Global Ketorolac Injection Market Value Comparison by Concentration (2024-2030) & (US$ Million)
    Table 2. Global Ketorolac Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Ketorolac Injection Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Ketorolac Injection Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Ketorolac Injection Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Ketorolac Injection Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Ketorolac Injection Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Ketorolac Injection Average Price (US$/K Units) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Ketorolac Injection, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Ketorolac Injection, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Ketorolac Injection, Product Type & Application
    Table 12. Global Key Manufacturers of Ketorolac Injection, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Ketorolac Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Ketorolac Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Ketorolac Injection Sales by Region (2019-2024) & (K Units)
    Table 18. Global Ketorolac Injection Sales Market Share by Region (2019-2024)
    Table 19. Global Ketorolac Injection Sales by Region (2025-2030) & (K Units)
    Table 20. Global Ketorolac Injection Sales Market Share by Region (2025-2030)
    Table 21. Global Ketorolac Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Ketorolac Injection Revenue Market Share by Region (2019-2024)
    Table 23. Global Ketorolac Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Ketorolac Injection Revenue Market Share by Region (2025-2030)
    Table 25. North America Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Ketorolac Injection Sales by Country (2019-2024) & (K Units)
    Table 27. North America Ketorolac Injection Sales by Country (2025-2030) & (K Units)
    Table 28. North America Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Ketorolac Injection Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Ketorolac Injection Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Ketorolac Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Ketorolac Injection Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Ketorolac Injection Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Ketorolac Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Ketorolac Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Ketorolac Injection Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Ketorolac Injection Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Ketorolac Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Ketorolac Injection Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Ketorolac Injection Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Ketorolac Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Ketorolac Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Ketorolac Injection Sales (K Units) by Concentration (2019-2024)
    Table 51. Global Ketorolac Injection Sales (K Units) by Concentration (2025-2030)
    Table 52. Global Ketorolac Injection Sales Market Share by Concentration (2019-2024)
    Table 53. Global Ketorolac Injection Sales Market Share by Concentration (2025-2030)
    Table 54. Global Ketorolac Injection Revenue (US$ Million) by Concentration (2019-2024)
    Table 55. Global Ketorolac Injection Revenue (US$ Million) by Concentration (2025-2030)
    Table 56. Global Ketorolac Injection Revenue Market Share by Concentration (2019-2024)
    Table 57. Global Ketorolac Injection Revenue Market Share by Concentration (2025-2030)
    Table 58. Global Ketorolac Injection Price (US$/K Units) by Concentration (2019-2024)
    Table 59. Global Ketorolac Injection Price (US$/K Units) by Concentration (2025-2030)
    Table 60. Global Ketorolac Injection Sales (K Units) by Application (2019-2024)
    Table 61. Global Ketorolac Injection Sales (K Units) by Application (2025-2030)
    Table 62. Global Ketorolac Injection Sales Market Share by Application (2019-2024)
    Table 63. Global Ketorolac Injection Sales Market Share by Application (2025-2030)
    Table 64. Global Ketorolac Injection Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Ketorolac Injection Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Ketorolac Injection Revenue Market Share by Application (2019-2024)
    Table 67. Global Ketorolac Injection Revenue Market Share by Application (2025-2030)
    Table 68. Global Ketorolac Injection Price (US$/K Units) by Application (2019-2024)
    Table 69. Global Ketorolac Injection Price (US$/K Units) by Application (2025-2030)
    Table 70. Pfizer Corporation Information
    Table 71. Pfizer Description and Business Overview
    Table 72. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 73. Pfizer Ketorolac Injection Product
    Table 74. Pfizer Recent Developments/Updates
    Table 75. Fresenius Kabi Corporation Information
    Table 76. Fresenius Kabi Description and Business Overview
    Table 77. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 78. Fresenius Kabi Ketorolac Injection Product
    Table 79. Fresenius Kabi Recent Developments/Updates
    Table 80. Fosun Pharma (Gland Pharma) Corporation Information
    Table 81. Fosun Pharma (Gland Pharma) Description and Business Overview
    Table 82. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 83. Fosun Pharma (Gland Pharma) Ketorolac Injection Product
    Table 84. Fosun Pharma (Gland Pharma) Recent Developments/Updates
    Table 85. Sagent Pharmaceuticals Corporation Information
    Table 86. Sagent Pharmaceuticals Description and Business Overview
    Table 87. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 88. Sagent Pharmaceuticals Ketorolac Injection Product
    Table 89. Sagent Pharmaceuticals Recent Developments/Updates
    Table 90. Hikma Corporation Information
    Table 91. Hikma Description and Business Overview
    Table 92. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 93. Hikma Ketorolac Injection Product
    Table 94. Hikma Recent Developments/Updates
    Table 95. Lunan Pharma Corporation Information
    Table 96. Lunan Pharma Description and Business Overview
    Table 97. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 98. Lunan Pharma Ketorolac Injection Product
    Table 99. Lunan Pharma Recent Developments/Updates
    Table 100. Alvogen Corporation Information
    Table 101. Alvogen Description and Business Overview
    Table 102. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 103. Alvogen Ketorolac Injection Product
    Table 104. Alvogen Recent Developments/Updates
    Table 105. Chengdu Brilliant Pharmaceuticals Corporation Information
    Table 106. Chengdu Brilliant Pharmaceuticals Description and Business Overview
    Table 107. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 108. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product
    Table 109. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
    Table 110. Athenex Corporation Information
    Table 111. Athenex Description and Business Overview
    Table 112. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 113. Athenex Ketorolac Injection Product
    Table 114. Athenex Recent Developments/Updates
    Table 115. Sichuan Medcalo Corporation Information
    Table 116. Sichuan Medcalo Description and Business Overview
    Table 117. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 118. Sichuan Medcalo Ketorolac Injection Product
    Table 119. Sichuan Medcalo Recent Developments/Updates
    Table 120. Julphar Bangladesh Ltd. Corporation Information
    Table 121. Julphar Bangladesh Ltd. Description and Business Overview
    Table 122. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 123. Julphar Bangladesh Ltd. Ketorolac Injection Product
    Table 124. Julphar Bangladesh Ltd. Recent Developments/Updates
    Table 125. Yung Shin Pharm Corporation Information
    Table 126. Yung Shin Pharm Description and Business Overview
    Table 127. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 128. Yung Shin Pharm Ketorolac Injection Product
    Table 129. Yung Shin Pharm Recent Developments/Updates
    Table 130. Tianjin Chase Sun Pharmaceutical Corporation Information
    Table 131. Tianjin Chase Sun Pharmaceutical Description and Business Overview
    Table 132. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 133. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product
    Table 134. Tianjin Chase Sun Pharmaceutical Recent Developments/Updates
    Table 135. ZISKA Pharmaceuticals Corporation Information
    Table 136. ZISKA Pharmaceuticals Description and Business Overview
    Table 137. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 138. ZISKA Pharmaceuticals Ketorolac Injection Product
    Table 139. ZISKA Pharmaceuticals Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Ketorolac Injection Distributors List
    Table 143. Ketorolac Injection Customers List
    Table 144. Ketorolac Injection Market Trends
    Table 145. Ketorolac Injection Market Drivers
    Table 146. Ketorolac Injection Market Challenges
    Table 147. Ketorolac Injection Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Ketorolac Injection
    Figure 2. Global Ketorolac Injection Market Value Comparison by Concentration (2024-2030) & (US$ Million)
    Figure 3. Global Ketorolac Injection Market Share by Concentration in 2023 & 2030
    Figure 4. 15mg/ml Product Picture
    Figure 5. 30mg/ml Product Picture
    Figure 6. Global Ketorolac Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Ketorolac Injection Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Global Ketorolac Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Ketorolac Injection Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Ketorolac Injection Sales (2019-2030) & (K Units)
    Figure 14. Global Ketorolac Injection Average Price (US$/K Units) & (2019-2030)
    Figure 15. Ketorolac Injection Report Years Considered
    Figure 16. Ketorolac Injection Sales Share by Manufacturers in 2023
    Figure 17. Global Ketorolac Injection Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Ketorolac Injection Players: Market Share by Revenue in 2023
    Figure 19. Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Ketorolac Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Ketorolac Injection Sales Market Share by Country (2019-2030)
    Figure 22. North America Ketorolac Injection Revenue Market Share by Country (2019-2030)
    Figure 23. United States Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Ketorolac Injection Sales Market Share by Country (2019-2030)
    Figure 26. Europe Ketorolac Injection Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Ketorolac Injection Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Ketorolac Injection Revenue Market Share by Region (2019-2030)
    Figure 34. China Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Ketorolac Injection Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Ketorolac Injection Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Ketorolac Injection Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Ketorolac Injection Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Ketorolac Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Ketorolac Injection by Concentration (2019-2030)
    Figure 54. Global Revenue Market Share of Ketorolac Injection by Concentration (2019-2030)
    Figure 55. Global Ketorolac Injection Price (US$/K Units) by Concentration (2019-2030)
    Figure 56. Global Sales Market Share of Ketorolac Injection by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Ketorolac Injection by Application (2019-2030)
    Figure 58. Global Ketorolac Injection Price (US$/K Units) by Application (2019-2030)
    Figure 59. Ketorolac Injection Value Chain
    Figure 60. Ketorolac Injection Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions